Human TGFB1 ELISA Kit, Lot 21AO-1111 [Cancer Immune Checkpoint Assay Kit]

The kit is designed for in vitro quantitative measurement of Human TGFB1 in Cell Culture Supernatant, Serum, Plasma (heparin), Plasma (citrate), Plasma (EDTA).

ELISA

Detection Wavelength: 450 nm

TGFB1

Human

Colorimetric

Sandwich ELISA

Quantitative

Cell Culture Supernatant, Serum, Plasma (heparin), Plasma (citrate), Plasma (EDTA)

Natural and recombinant Human TGF-β1 Ligand

Microplate reader.
Pipettes and pipette tips.
EP tube Deionized or distilled water.

15 pg/mL

20 μL

3 h

Pre-coated

4 °C

For Research Use only

Transforming Growth factor beta1

CED; DPD1; LAP; TGFB; TGFbeta; TGF-beta; TGF-BETA-1; TGF-beta5; ced; dpd1; lap; tgf-beta; tgfb; tgfb5; tgfbeta; TGF-beta1; TGFbeta1; Tgfb; Tgfb-1; ai39657; tgfb1; wu:fb13a07; xx:ai39657; TGFB1; csd; cdb1; cdg2; csd1; csd2; csd3; ebmd; lcd1; bigh3; cdgg1; betaig-h3; TGFB4; transforming growth factor beta 1; transforming growth factor beta-1; transforming growth factor beta 1 L homeolog; transforming growth factor; beta 1; transforming growth factor; beta 1a; transforming growth factor beta induced L homeolog; TGFB1; Tgfb1; tgfb1.L; tgfb1a; tgfbi.L

Transforming growth factor (TGF), a 'factor' that promoted the transformation of cultured fibroblasts into a tumor-like phenotype, was subsequently found to be more of a tumor suppressor than tumor promoter and to be a mixture of two proteins, TGF-α and TGF-β.

7040

P01137

EGFR Signaling Pathway, Dopaminergic Neurogenesis, Cellular Response to Molecule of Bacterial Origin, Glycosaminoglycan Metabolic Process, Regulation of Leukocyte Mediated Immunity, Regulation of Muscle Cell Differentiation, Positive Regulation of Immune Effector Process, Cell-Cell Junction Organization, Production of Molecular Mediator of Immune Response, Ribonucleoside Biosynthetic Process, Skeletal Muscle Fiber Development, Regulation of Carbohydrate Metabolic Process, Protein targeting to Nucleus, Autophagy, Cancer Immune Checkpoints